Watson Biosimilar Tie Up With Itero Plays Into Women's Health Expertise
This article was originally published in The Pink Sheet Daily
Executive Summary
Watson licenses rights to a recombinant follicle stimulating hormone in preclinical development that would reference Merck-Serono's infertility drug Gonal-f.